|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7100 EUR | -4.57% |
|
-8.74% | +414.49% |
| 07-16 | Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies | MT |
| 07-16 | Valerio Therapeutics, Abivax Sign R&D Deal for Inflammatory Diseases' Drug Candidates | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.57% | -8.74% | +39.22% | +348.23% | +414.49% | +975.76% | +206.03% | +19.93% | -76.87% | 428M | |
| -0.51% | -6.83% | -8.09% | +15.81% | +3.82% | +46.35% | +148.39% | +335.83% | +1,248.74% | 1T | |
| +0.20% | -4.14% | -3.08% | +12.21% | +23.18% | +52.35% | +49.40% | +46.18% | +105.75% | 613B | |
| -0.53% | -5.10% | -6.62% | +18.01% | +6.70% | +24.88% | +63.57% | +109.72% | +266.23% | 433B | |
| +0.48% | -0.67% | +5.02% | +12.34% | +8.99% | +39.13% | +34.00% | +1.40% | +46.60% | 350B | |
| +0.08% | -3.05% | -2.60% | +7.51% | +13.69% | +32.29% | +39.91% | +49.26% | +55.75% | 292B | |
| +2.09% | -8.91% | -18.79% | -13.11% | -14.87% | +5.73% | +7.71% | +41.50% | +134.05% | 239B | |
| +1.75% | -5.79% | -5.90% | +10.65% | -5.43% | -0.39% | -42.69% | +5.51% | +67.81% | 206B | |
| +2.94% | +3.66% | +4.24% | +18.25% | +19.16% | +31.37% | +69.06% | +59.79% | +124.89% | 204B | |
| +3.13% | +3.62% | +3.03% | +2.73% | +10.19% | +19.50% | +79.07% | +93.68% | +68.87% | 163B | |
| +1.52% | +3.00% | +4.48% | -3.49% | +2.05% | +8.17% | -27.40% | -44.37% | -28.00% | 143B | |
| +0.64% | +5.32% | +13.35% | +13.17% | +22.15% | +48.97% | +7.61% | -4.93% | -11.91% | 134B | |
| +1.70% | -0.06% | -9.34% | +12.92% | +5.59% | +3.59% | +37.66% | +139.29% | +376.61% | 119B | |
| +0.26% | -2.37% | -4.99% | +0.71% | +4.93% | +37.09% | +42.30% | +6.85% | -8.42% | 103B | |
| -0.15% | -4.37% | -1.87% | -6.80% | -10.07% | -7.41% | -19.33% | -13.95% | +1.32% | 103B | |
| -0.10% | -2.45% | -12.59% | -18.98% | -18.96% | -8.99% | +60.89% | +66.83% | +440.16% | 70.18B | |
| -2.26% | -8.37% | -1.36% | +0.90% | +9.33% | +25.35% | +21.16% | +44.74% | +11.94% | 55.08B | |
| +2.40% | +2.16% | -9.58% | +26.81% | +30.37% | +71.59% | -6.47% | -3.71% | -48.87% | 53.26B | |
| +0.79% | -0.34% | -1.89% | -0.85% | -10.32% | -12.87% | +26.38% | -6.93% | +228.62% | 51.77B | |
| -1.27% | -3.38% | -1.81% | +3.95% | -4.56% | -2.11% | +10.08% | - | - | 42.85B | |
| Average | +0.37% | -2.66% | -0.96% | +23.05% | +25.52% | +69.52% | +40.37% | +49.82% | +158.07% | 218.77B | |
| Weighted average by Cap. | +0.62% | -3.63% | -3.94% | +9.93% | +7.45% | +31.69% | +59.60% | +110.93% | +374.76% |
- Stock Market
- Stocks
- ALVIO Stock
- Sector Valerio Therapeutics
Select your edition
All financial news and data tailored to specific country editions
